John Dobbins
About John Dobbins
John Dobbins is the Director of WW Hematology Business Development and Clinical Collaborations at Bristol Myers Squibb and serves on the Board of Visitors for Cardiology at The Children's Hospital of Philadelphia. He has over 20 years of experience in the pharmaceutical and healthcare industries, with a strong background in business development and clinical collaborations in hematology.
Company
John Dobbins currently holds a significant role at Bristol Myers Squibb as the Director of WW Hematology Business Development and Clinical Collaborations. In this position, he operates from Lawrenceville, NJ, focusing on strategic partnerships and collaborations in the hematology sector. His work involves active engagement with clinical collaborations to advance research and treatments in hematology.
Title
John Dobbins is the Director of WW Hematology Business Development and Clinical Collaborations at Bristol Myers Squibb. In addition to his responsibilities at Bristol Myers Squibb, he serves on the Board of Visitors for Cardiology at The Children's Hospital of Philadelphia, where he provides advisory support.
Education and Expertise
John Dobbins has a robust educational background with a Master of Business Administration (MBA) in Finance from the NYU Stern School of Business, completed between 1998 and 2001. He also holds a Bachelor of Science (BS) in Biochemistry from Penn State University, where he studied from 1988 to 1992. His educational qualifications complement his extensive experience in both business development and clinical collaborations within the pharmaceutical and healthcare industries.
Background
John Dobbins has over 20 years of experience in the pharmaceutical and healthcare industries. His career includes significant roles such as Director at Navigant from 2010 to 2020, VP and Group Account Supervisor at Saatchi & Saatchi Healthcare Innovations from 2003 to 2010, and Product Manager at Sankyo Pharma from 2001 to 2003. Additionally, he has experience as an Account Supervisor at SSHC and as a Market Analyst at Roche Pharmaceuticals.
Achievements
At Bristol Myers Squibb, John Dobbins has led strategic partnerships and collaborations in the hematology sector. He has played a key role in the launch of multiple hematology products, advancing both research and treatments. His active involvement in clinical collaborations has been instrumental in pushing forward hematology research and innovative treatments in the field.